Trials / Completed
CompletedNCT03856814
Market Penetration of Laser Therapy in Venous Surgery: Ziekenhuis Oost-Limburg - Ziekenhuis Maas En Kempen Center Experience
Market Penetration of Laser Therapy in Venous Surgery: ZOL - ZMK Center Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Duomed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this registry is to evaluate the indication for EndoVenous Laser Ablation (EVLA) therapy. Can this be enhanced? What are the reasons for not using the laser? Therefore, this study aims to define clear indications for EVLA by registering the incentives of the participating investigators to use the laser instead of conventional corrective surgery for the treatment of varicose veins, at baseline and post-operative. Additionally, the efficacy and safety of the different varicose vein treatments will be evaluated by registering procedural characteristics, anatomic outcome (duplex ultrasound), quality of life (AVVQ) and postoperative pain (VAS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ELVeS® Radial® 2ring slim fiber used for EndoVenous Laser Ablation | Device for endovenous laser ablation manufactured by Biolitec AG company (ELVeS system) - diode laser with a wavelength of 1470 nm |
Timeline
- Start date
- 2019-03-15
- Primary completion
- 2023-01-13
- Completion
- 2023-11-08
- First posted
- 2019-02-27
- Last updated
- 2024-09-05
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03856814. Inclusion in this directory is not an endorsement.